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As a first step to directly test this model, we used isothermal titration calorimetry (ITC) to quantify the interactions of Rho family GTPases and the SH3 domain of IRSp53 with both the isolated CRIB-PR and full-length IRSp53 (FL, Fig. 1a and Supplementary  Fig. 1a) . In these experiments, we used a constitutively active mutant (G12V) of the two GTPases suggested to activate IRSp53: Cdc42 (refs. 16, 31) and Rac1 (ref. 19) . We exchanged the nucleotide on the GTPases with either GDP or GMP-PNP and confirmed the nucleotide state before each ITC experiment by HPLC (as described in ref. 48 ). GMP-PNP-Cdc42 G12V bound FL with a dissociation constant (K d ) of 16.1 µM. The affinity of GMP-PNP-Cdc42 G12V for the isolated CRIB-PR was three-fold higher (K d = 5.0 µM) (Fig. 1c,d ), a result suggesting that the CRIB-PR is partially occluded in the full-length protein, presumably by intramolecular inhibitory interactions. Of note, these affinities are lower than those of Cdc42 and Rac for canonical CRIB motifs, including those of ACK, PAK, PAR6 and WASP, typically ranging from 1 to 50 nM (refs. 42, 49, 50) . Neither GDP-Cdc42 G12V nor GMP-PNP-Rac1 G12V bound to FL or the isolated CRIB-PR, indicating that the interaction is both GTPase and nucleotide specific.
The SH3 domain also bound to the isolated CRIB-PR domain (Fig. 1e) , albeit with low affinity (K d = 114 µM), which is common for autoinhibitory interactions that are enhanced by the proximity achieved within a single polypeptide 42, 51 . This reaction did not reach saturation, and therefore the stoichiometry of the interaction could not be determined. The affinity of the SH3 domain for FL was too low to be accurately quantified (Fig. 1e) , probably owing to competition with the endogenous SH3 domain. That both the SH3 domain and Cdc42 G12V bind to the CRIB-PR is consistent with a model of autoinhibition and competitive activation.
Autoinhibition and competitive activation would also be consistent with a conformational change upon Cdc42 binding. Indeed, the three-fold-reduced enthalpy of Cdc42 G12V binding to FL compared to CRIB-PR already suggested a reaction in which endothermic binding of Cdc42 G12V is offset by an exothermic conformational change. To explore this possibility, we developed a fluorescence resonance energy npg a r t i c l e s transfer (FRET) assay, using two different reporters based on IRSp53 constructs FL and BAR-SH3 (Supplementary Fig. 1b) . In both cases, we labeled pairs of cysteines with the donor probe fluorescein maleimide and the acceptor probe rhodamine maleimide. IRSp53 contains four endogenous cysteines, all within the BAR domain. By peptide mass fingerprinting, we found that only one of these cysteines (Cys230) reacted with the fluorescence probe ( Supplementary Fig. 1c ).
We added a second reactive cysteine by mutagenesis at the ends of constructs FL (S519C) and BAR-SH3 (S452C), such that changes in FRET were observed only for the full-length sensors. (Both proteins undergo partial C-terminal degradation.) To ensure that most of the donors were coupled to acceptors, we first under-labeled with the donor probe and then performed saturating labeling with the acceptor probe (Online Methods).
In the absence of Rho family GTPases, energy transfer (quenching) was present with both FRET reporters ( Fig. 1f-h) . Titration of GMP-PNP-Cdc42 G12V , but not GDP-Cdc42 G12V or GMP-PNP-Rac1 G12V , reduced the energy transfer, consistent with a Cdc42-dependent conformational change in IRSp53 that increases the distance between fluorescence probes. By fitting the fluorescence decrease as a function of GMP-PNP-Cdc42 G12V concentration, we found that Cdc42 G12V bound with an affinity approximately seven-fold weaker to FL (K d = 23.0 µM) than to BAR-SH3 (K d = 3.2 µM). This suggests that the region C terminal to the SH3 domain also participates in autoinhibitory interactions. We also note that the affinity of GMP-PNPCdc42 G12V for FL measured by the FRET reporter is remarkably similar to that measured by ITC (Fig. 1c) , mutually validating both affinity measurements.
The energy transfer between probes was unchanged during titration of the isolated SH3 domain (Fig. 1g,h ). This result is consistent with its lack of binding in ITC (Fig. 1e) and suggests that the SH3 domain interacts too weakly in trans to offset autoinhibitory interactions occurring intramolecularly.
Heterohexameric complex of IRSp53, Cdc42 and Eps8
The results described above suggested that activation of IRSp53 requires the detachment of the SH3 domain from the CRIB-PR domain. In principle, this detachment could also be achieved through the binding of an effector protein to the SH3 domain 24 . To test this hypothesis, we selected the IRSp53 effector Eps8, which is overexpressed in numerous cancers 14, 34 . We titrated Eps8 into the BAR-SH3 FRET reporter (Fig. 2a) . At saturation, Eps8 produced a total increase in donor fluorescence similar in magnitude to that produced by GMP-PNP-Cdc42 G12V (Fig. 2a) . The titration could not be fit to a singlesite binding model, owing to its biphasic character. Indeed, the donor fluorescence first decreased and then increased, with the transition between phases taking place at an Eps8/BAR-SH3 molar ratio of ~1:1.
(The concentration of BAR-SH3 in this experiment was 0.5 µM.) The second phase was best fit to a cooperative binding function, with Hill coefficient of 2.5 and K d of 1.0 µM. The biphasic and cooperative character of the interaction suggested that one molecule of Eps8 binds to one molecule of IRSp53 or, more likely, two Eps8 molecules bind to the IRSp53 dimer.
To more conclusively determine the stoichiometry of the Eps8-IRSp53 complex, we used size-exclusion chromatography combined with glycerol gradient sedimentation (Supplementary Fig. 2 ). This analysis showed that Eps8 is an elongated monomer in solution with a measured mass of 106,000 Da (theoretical mass, 114.8 Da), IRSp53 is a dimer as expected for a BAR-domain protein, and the two interact to form a 2:2 complex with a measured mass of 288,000 Da (theoretical mass, 298,600 Da).
To test whether IRSp53 could simultaneously bind Cdc42 and a downstream effector, we titrated the saturated Eps8-IRSp53 complex with Cdc42 G12V . This second titration produced a conformational change in addition to that generated by Eps8 (Fig. 2a) . To further investigate this point, we reversed the order of the experiment, by first titrating Cdc42 G12V into IRSp53 and then titrating Eps8. The results confirmed the additive character of the conformational changes induced by these two proteins on IRSp53 (Fig. 2b) . Cdc42 G12V bound to IRSp53 and to the Eps8-IRSp53 complex in a similar manner, i.e., noncooperatively (Hill coefficient < 2.0), albeit with a somewhat lower affinity for the complex (K d of 2.4 versus 10.7 µM). Eps8 also bound similarly to IRSp53 and the Cdc42 G12V -IRSp53 complex; in both cases, the interaction was cooperative (Hill coefficient > 2.0), and the affinities were nearly identical (K d of 1.0 versus 1.1 µM). Both Eps8 titrations displayed the characteristic biphasic binding described above.
These experiments showed that Cdc42 binding to the CRIB-PR and Eps8 binding to the SH3 domain both produce conformational changes in IRSp53, but these changes are of a different nature. Thus, independent of the order in which Cdc42 G12V and Eps8 were titrated into IRSp53, the total change in energy transfer at equilibrium was similar for both titrations, and was greater than for either Eps8 or Cdc42 G12V alone. These results suggest that Cdc42 G12V and Eps8 can bind simultaneously to IRSp53 and additively alter its structure to produce full activation. Because one Cdc42 G12V molecule binds to each of the CRIB-PR domains of IRSp53 (Fig. 1c,d) , and Eps8 forms a 2:2 complex with IRSp53 ( Supplementary Fig. 2 ), these results suggest that IRSp53, Cdc42 and Eps8 form a hexameric 2:2:2 complex. 
npg a r t i c l e s
Structure of GMP-PNP-Cdc42 G12V bound to the CRIB-PR We determined the crystal structure of GMP-PNP-Cdc42 G12V bound to the CRIB-PR domain at 1.9-Å resolution ( Table 1 , Fig. 3a and Supplementary Video 1). Amino acids Ser263-Ser291 of the CRIB-PR were well defined in the electron density map (Fig. 3b,c) . Three residues at the N terminus of the peptide were disordered in the structure and presumably do not interact with Cdc42. The structure reveals a new mode of GTPase binding to a CRIB-related sequence. Indeed, only the N-terminal portion of the CRIB-PR, up to residue Pro270, overlaps with classical CRIB motifs (Fig. 3d) .
Coincidentally, Pro270 is also the last residue of the CRIB-PR shared with canonical CRIB motifs (Fig. 1b) . From Pro270 to Pro280, the CRIB-PR chain meanders along a hydrophobic surface on Cdc42 (Fig. 3c) . Classical CRIB motifs take a different path, forming a β-strand that runs antiparallel to β-strand 2 of the GTPase and making hydrophobic and electrostatic contacts with switch I of the GTPase through their canonical FxHxxH C-terminal sequence that is missing in IRSp53 (Fig. 3d) . In contrast, in the CRIB-PR, the all-critical interaction with the switch I-switch II region is established through a short helix formed by residues Pro281-Phe286 and the last six amino acids of the CRIB-PR, which run parallel to switch I of Cdc42. Of these, the last five amino acids of the CRIB-PR appear somewhat more flexible; they display higher temperature factors and are less well defined in the electron density map.
Cellular and biochemical analysis of IRSp53 activation
A remarkable feature of the structure of the CRIB-PR bound to Cdc42 G12V is that it shows that a PR sequence, featuring a canonical SH3 domain-binding site, can specifically interact with a Rho family GTPase, providing a mechanism for competitive activation. To further test this unexpected observation, we designed IRSp53 truncations and mutations with different predicted effects on Cdc42 binding and autoinhibition and characterized their cellular and in vitro activities. In cells, we quantified the number and length of filopodia in B16F1 mouse melanoma cells expressing mCherry-Cdc42 G12V and IRSp53-GFP constructs. We defined filopodia as actin-filled, nontapered protrusions that emerged more than 1 µm from the cell periphery and had a width of 0.2-0.5 µm.
Individually, IRSp53 or Cdc42 did not increase the number or length of filopodia relative to those in control cells coexpressing GFP and RFP empty vectors (Supplementary Fig. 3a) . Thus, cells expressing mCherry-Cdc42 G12V and GFP showed Cdc42 G12V uniformly enriched along the plasma membrane and diffusely distributed in the cytoplasm ( Fig. 4a and Supplementary Fig. 3b ), but the number and length of filopodia were mostly unchanged (Fig. 4i,j) . Cells expressing FL-GFP and RFP showed IRSp53 localized in patches along the plasma membrane and in the cytoplasm ( Fig. 4b and Supplementary Fig. 3c ), but the number and length of filopodia did not change (Fig. 4i,j) . 
In contrast, there was a dramatic increase in the number and length of filopodia in cells coexpressing FL-GFP and mCherry-Cdc42 G12V (Fig. 4c,i,j) . Moreover, in these cells IRSp53 became uniformly distributed along the plasma membrane (Supplementary Fig. 3d) . Therefore, we classified construct FL as fully 'regulated' , because its filopodia-inducing activity and proper plasma-membrane localization depended on coexpression with Cdc42 G12V . Interestingly, as filopodia became longer, they frequently showed unusual characteristics: they became segmented, as indicated by periodic nodes of enhanced IRSp53 and Cdc42 G12V colocalization, and occasionally they also formed branches at the sites of these nodes (Fig. 4c) . We refer to these structures as filopodia-like protrusions.
By comparison, we classified constructs BAR and BAR-CRIB-PR as 'unregulated' , because they produced a large increase in the number of filopodia or filopodia-like protrusions independently of coexpression with Cdc42 G12V (Fig. 4d,e,i,j) . Of these protrusions, 20-35% were not filled with actin (Fig. 4k) or were only partially filled. This result is consistent with the inability of constructs BAR and BAR-CRIB-PR to recruit downstream actin assembly effectors that bind to the SH3 domain. Curiously, however, filopodia length with these two constructs increased as a function of Cdc42 G12V coexpression (Fig. 4j) . Because only one of these constructs can bind Cdc42 G12V (BAR-CRIB-PR), this result suggests that once filopodia are initiated Cdc42 G12V controls their length through mechanisms independent of its interaction with IRSp53.
Construct BAR-SH3 displayed an intermediate phenotype between FL and BAR, and therefore we classified it as 'partially regulated' . This construct increased the number and length of filopodia or filopodialike protrusions (Fig. 4f,i,j) , and the majority of these protrusions were actin filled (Fig. 4k) , consistent with the ability of BAR-SH3 to recruit actin assembly factors through the SH3 domain. However, filopodia induction was only partially dependent on Cdc42 G12V coexpression (Fig. 4i) , suggesting that construct BAR-SH3 is not fully inhibited. This is consistent with our finding that sequences C terminal to the SH3 domain participate in autoinhibition (Fig. 1g) .
Next, we tested the effect of point mutations within the CRIB-PR domain, which were suggested by the structure to disrupt Cdc42 G12V binding (Fig. 3c) and thus to interfere with Cdc42-dependent activation in cells. A BAR-SH3 double mutant targeting two highly conserved residues in the N-terminal portion of the CRIB-PR, I267A S268A, failed to bind Cdc42 G12V by ITC (Supplementary Fig. 4) , confirming the importance of canonical CRIB residues for this interaction. 
npg a r t i c l e s
Another double mutant, L277E F286E, targeting hydrophobic interactions of two residues in the PR region, also failed to bind Cdc42 G12V (Supplementary Fig. 4) . Moreover, the mutation F286E alone was sufficient to abrogate Cdc42 G12V binding to IRSp53 (Supplementary Fig. 4) , demonstrating the importance of the PR region for interaction with Cdc42 G12V . Phe286 binds at the interface between switches I and II, suggesting that the PR region also has a key role in sensing the nucleotide state of the GTPase. Coexpression of Cdc42 G12V with FL mutants I267A S268A (Fig. 4g) or L277E F286E (Fig. 4h) resulted in a phenotype similar to that of FL expressed alone (Fig. 4b); i.e., filopodia number and length were unchanged as compared to control cells, with or without Cdc42 G12V (Fig. 4i,j) . These results suggest that these two mutants are trapped in a constitutively inactive state. These results also confirm that filopodia initiation by full-length IRSp53 requires interaction with Cdc42 as a prerequirement for filopodia elongation that depends on Cdc42 but not on its interaction with IRSp53.
These results are consistent with previous cellular work 16,18,31,52 that analyzed IRSp53 mutants, some of which were similar to those studied here (Fig. 4c-e,g ). Some of these mutants are reproduced here as a control for additional structure-inspired mutagenesis addressing autoinhibition.
Cellular and biochemical analysis of IRSp53 autoinhibition
The data presented to this point address the mechanism of IRSp53 coactivation by Cdc42 and effectors such as Eps8. Next, we set out to test the mechanism of autoinhibition, which appears to involve an interaction between the CRIB-PR and SH3 domains ( Fig. 1e  and Supplementary Fig. 5a ). To test this interaction, we designed CRIB-PR and SH3-domain mutants and characterized their in vitro and cellular activities.
The only canonical SH3 domain-binding PxxP site in IRSp53 is found within the CRIB-PR (278-PVPP-281). Interestingly, Pro278 and Pro281 are exposed in the structure and do not interact with Cdc42 directly, potentially allowing for the competitive binding of the SH3 domain of IRSp53 itself or that of a downstream effector (Supplementary Fig. 5a ). We mutated these residues to aspartic acid to disrupt potential interactions with SH3 domains. As suggested by the structure, the affinity of Cdc42 G12V for the BAR-SH3 double mutant P278D P281D was reduced only two-fold compared to that of wild type (K d of 10.7 versus 4.7 µM) (Fig. 5a) . However, as predicted by the model of autoinhibition, the binding of Cdc42 G12V produced only a minor conformational change in the FRET reporter (Fig. 5b) , suggesting that its conformation was already mostly open. 
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To further explore the conformation of this mutant, we titrated Eps8 into the BAR-SH3 FRET reporter mutant. This resulted in a biphasic conformational transition that fitted to a cooperative binding curve with similar affinity to that of wild type (Figs. 2a and 5c ). This result shows that the SH3 domain of Eps8 does not interact with the CRIB-PR of IRSp53, and the interaction probably involves the SH3 domain of IRSp53 and one of the PR sequences of Eps8 (refs. 14,15,34) . In contrast, binding of Cdc42 G12V to the Eps8-IRSp53 complex produced only a minor change in FRET (Fig. 5c) . This finding reaffirms the notion that the conformational changes produced by the binding of Cdc42 G12V to the CRIB-PR and of Eps8 to the SH3 domain are different in nature and additive in magnitude (Fig. 2) .
In cells, the FL mutant P278D P281D displayed a significant increase in the basal number of filopodia (Fig. 5d) . However, coexpression with Cdc42 G12V did not increase the number of filopodia, suggesting that the two-fold-lower affinity of this mutant for Cdc42 G12V observed in vitro (Fig. 5a ) is sufficient to abrogate Cdc42 G12V -dependent regulation in cells. In contrast, filopodia length increased with Cdc42 G12V coexpression (Fig. 5d) , and long filopodia-like protrusions were often segmented and buckled as described above.
To address the role of the SH3 domain in autoinhibition, we introduced the mutation P428L in the SH3 domain ( Supplementary  Fig. 5a ). This amino acid is strictly conserved in the SH3 fold and has been mutated in cellular studies to abolish effector binding to IRSp53 (refs. 16, 18) . The P428L mutant behaved similarly to the P278D P281D double mutant, producing a high basal number of filopodialike protrusions independently of Cdc42 G12V coexpression. Filopodia length was only marginally increased with Cdc42 G12V coexpression, and ~20% of these filopodia were not actin filled ( Supplementary  Fig. 5b) . These results suggest that the P428L mutation disrupts autoinhibitory interactions and recruitment of downstream effectors in cells. In vitro, however, this mutant could not be analyzed, owing to instability and protein degradation.
To more directly test the role of the SH3 domain in autoinhibition, we swapped the SH3 domain of IRSp53 for that of Eps8 that was established here not to bind to the CRIB-PR (compare Figs. 2 and 5c) . Although the two SH3 domains share low sequence identity (15%), their crystal structures have been determined, allowing for a precise definition of domain boundaries for swapping (Fig. 6a) . By ITC, Cdc42 G12V bound to the domain-swapped mutant (SH3-SWAP) npg a r t i c l e s with higher affinity than to FL (K d of 3.8 versus 16.1 µM) but with similar affinity as to the isolated CRIB-PR (Fig. 1d) , suggesting that this mutation breaks autoinhibitory interactions. Consistent with this result, the binding of Cdc42 G12V to a FL FRET reporter carrying this mutation did not produce a conformational change, suggesting that its conformation was already open. In cells, this mutant displayed a phenotype similar to mutants P278D P281D and P428L, in that it produced a high basal number of filopodia (Fig. 6d) . Cdc42 G12V coexpression led to an increase in the length and number of filopodia, ~10% of which were not actin filled. The increase in the number of filopodia was unexpected and may result from the specific activity of the Eps8 SH3 domain.
DISCUSSION
By linking signaling pathways to membrane and actin-cytoskeleton dynamics, I-BAR domain-containing proteins have critical roles in numerous cellular functions involving membrane remodeling [3] [4] [5] .
Previous studies have addressed the molecular mechanism by which the BAR domain can sense and/or induce membrane curvature 2, 53 . Much less is known about the mechanisms by which BAR domaincontaining proteins are regulated. These proteins are characterized by their modular architecture comprising domains specialized in the recruitment of cytoskeletal effectors that enhance or modulate their membrane-deforming activities. Thus, several BAR-domain proteins interact with small GTPases and contain SH3 domains through which they recruit proline-rich effectors in a regulated manner 2 . In this work, we have presented evidence, both in vitro and in cells, that the unique GTPase-binding domain of IRSp53, which we have named CRIB-PR, serves a dual role: autoinhibition and Cdc42-dependent membrane recruitment and activation. Similarly, we have shown that the SH3 domain also serves a dual role: autoinhibition and effector recruitment.
Nucleotide and GTPase specificity of the CRIB-PR domain
The interaction of the CRIB-PR with Cdc42 differs substantially from that of canonical CRIB motifs; the CRIB-PR binds with weaker affinity and interacts with a different surface on the GTPase than do canonical CRIB motifs 41, 49, 50, 54 . Only residues 267-ISDP-270 of the CRIB-PR, shared with canonical CRIB motifs, overlap with existing structures. Despite these differences, two basic principles of GTPase-effector binding are preserved: nucleotide-state sensing and exquisite GTPase specificity. Indeed, the C-terminal PR portion of the CRIB-PR interacts with the switch I-switch II region of Cdc42 that undergoes a nucleotide-dependent conformational change (Supplementary Fig. 6a ). This conformational change explains the inability of GDP-Cdc42 to bind to the CRIB-PR. It thus emerges that the PR portion of the CRIB-PR, involved in autoinhibitory interactions with the SH3 domain, is also responsible for GTPase nucleotide-state sensing. Rho family GTPases are highly conserved, with Cdc42 and Rac sharing 72% sequence identity. It was therefore surprising that Rac1 did not bind to the CRIB-PR, particularly given that IRSp53 was initially identified as a downstream effector of Rac 19 . Some CRIB motifs, including those of PAK protein kinases, appear to bind both Cdc42 and Rac 54 , whereas the CRIB motifs of ACK and WASP bind only Cdc42 (refs. 41,49) . Therefore, the question arises as to how is specificity achieved. To address this question, we calculated the conservation scores of each residue among the three Rac (Rac1, Rac2 and Rac3) and two Cdc42 (Cdc42-1 and Cdc42-2) variants expressed in humans, by using the program Consurf 55 . A surface representation of the Cdc42 structure, colored according to residue conservation scores, highlights an area of high sequence variation that coincides with the site where the structure of the CRIB-PR diverges from those of canonical CRIB motifs ( Fig. 3d and Supplementary Fig. 6b) . It thus appears that the sequence and structural divergence between the CRIB-PR and canonical CRIB motifs coincides with a site of sequence variation between Cdc42 and Rac. This suggests that the CRIB-PR is specifically adapted for binding to Cdc42.
Model of IRSp53 inhibition and combinatorial activation
Coincident activation is a common theme among cytoskeletal proteins, whereby various inputs work synergistically for efficient activation and localization. For instance, N-WASP adopts a compact autoinhibited conformation in the resting state, with full activation requiring the concurrent binding of Cdc42, negatively charged membranes, and SH3-containing binding partners 41, 42 . Similarly, some formins are maintained in an inactive state through intramolecular interaction of the C-terminal DAD and N-terminal DID domains. Activation and membrane localization is attained through multiple inputs, including binding of GTPases to a site near the DID 43, 44, 56 and concurrent interaction with the plasma membrane through the N-terminal basic tail 57, 58 . Another example is the WAVE complex, which is activated at the membrane by phosphorylation and simultaneous interactions with Rac and acidic phospholipids 45, 46 .
We propose that, analogous to these examples, the activation and localization of IRSp53 is a combinatorial process involving dimerization, GTPase binding, effector binding, membrane binding, and cooperative clustering at the membrane (Fig. 7) . IRSp53 is an antiparallel dimer, such that most of its interactions are enhanced by duplication. This includes autoinhibitory interactions that, as shown here, involve the CRIB-PR and SH3 domain (Figs. 1e, 5 and 6 ) as well as sequences C terminal to the SH3 domain (Figs. 1g and 4c,f) . We also established that autoinhibitory interactions are weak (Fig. 1e) , but are likely to be enhanced by the proximity of the interacting domains within a single polypeptide 51 . Moreover, autoinhibitory interactions must be reversible, so their weak affinity probably has a functional role. In the inhibited state, IRSp53 is not uniformly localized to the plasma membrane (Fig. 4b) , suggesting that autoinhibitory interactions weaken membrane binding and/or IRSp53 clustering at the membrane 59 . Autoinhibition also occludes the SH3 domain, which is necessary for effector binding. (Fig. 4c) , which is itself tethered to the membrane. Activation at the plasma membrane appears to occur as a two-step process culminating with the formation of a hexameric 2:2:2 complex between Cdc42, IRSp53 and downstream effectors such as Eps8. We have shown here that the binding site of Cdc42, comprising the entire CRIB-PR, overlaps with the binding site of the SH3 domain on the PR region, revealing the structural bases for competitive activation by Cdc42. However, as in other autoinhibitory interactions 43, 44 , the overlap is not complete, because the PxxP motif is partially exposed in the structure (Supplementary Fig. 5a ).
Cdc42 binding to the CRIB-PR and effector binding to the SH3 domain both produce conformational changes on IRSp53 that are similar in magnitude but different in nature, which when combined produce a more open and presumably fully activated state (Figs. 2  and 7) . This may explain how coexpression of IRSp53 with either Cdc42 or some downstream effectors enhances IRSp53 localization at the plasma membrane 13, 16, 18, 19 . Finally, BAR-BAR interactions may allow IRSp53 to form a coat at the membrane, necessary for membrane deformation 6, 59 . In summary, we have shown that through a highly specialized modular structure, IRSp53 constitutes a node for integration of signaling and functional inputs at the interface between the plasma membrane and the actin cytoskeleton.
METHODS
Methods and any associated references are available in the online version of the paper. 
